Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07UKF
|
||||
| Former ID |
DIB001168
|
||||
| Drug Name |
VBY-129
|
||||
| Synonyms |
Cathepsin S inhibitor (oral, psoriasis), Virobay
|
||||
| Indication | Autoimmune diabetes [ICD10:E08-E13] | Phase 1 | [551766] | ||
| Company |
Virobay Inc
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin S | Target Info | Inhibitor | [551767] | |
| NetPath Pathway | Leptin Signaling Pathway | ||||
| IL2 Signaling Pathway | |||||
| References | |||||